PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,341,333 | -71.3% | 74,025 | -57.9% | 0.01% | -75.0% |
Q1 2023 | $4,678,275 | +214.0% | 175,875 | +128.2% | 0.02% | +150.0% |
Q4 2022 | $1,489,763 | +165.1% | 77,070 | +186.5% | 0.01% | +166.7% |
Q3 2022 | $562,000 | +420.4% | 26,901 | +99.9% | 0.00% | +200.0% |
Q2 2022 | $108,000 | – | 13,459 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |